SCHEMBL15037585

SCHEMBL15037585

C[N+]1(C)CCN(CCN2CCCc3ccc(N)cc32)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.40
BRD4 O60885 1/20 0.40
ATAD2 Q6PL18 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
REN P00797 8/20 0.37
CYP3A4 P08684 4/20 0.36
MAPK1 P28482 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
CASP1 P29466 1/20 0.34
HTT P42858 1/20 0.34
CASP7 P55210 1/20 0.34
SMAD3 P84022 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12333948 0.92 ALDH1A1 (0.41) BRD4ATAD2KMT2AMEN1ALDH1A1
Hydrochloric Acid SCHEMBL14815634 0.90 ALDH1A1 (0.39) BRD4ATAD2KMT2AMEN1ALDH1A1
SCHEMBL15037630 0.89 REN (0.38) HRH3BRD4ATAD2KMT2AMEN1
SCHEMBL15037706 0.87 HRH3 (0.47) HRH3BRD4ATAD2KMT2AMEN1
SCHEMBL15037993 0.87 HRH3 (0.43) HRH3BRD4ATAD2KMT2AMEN1
SCHEMBL15037578 0.86 HRH3 (0.40) HRH3BRD4ATAD2KMT2AMEN1
SCHEMBL15037988 0.86 HRH3 (0.48) HRH3BRD4ATAD2KMT2AMEN1
Hydrochloric Acid SCHEMBL15016566 0.85 KMT2A (0.44) HRH3BRD4ATAD2KMT2AMEN1
SCHEMBL15037989 0.85 HRH3 (0.50) HRH3BRD4ATAD2KMT2AMEN1
SCHEMBL15016508 0.84 BRD4 (0.39) HRH3BRD4ATAD2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9107848-B2 Coupler with cationic 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses L'OREAL (FR) 2015-08-18 US disclosed
US-20140352713-A1 COUPLER WITH CATIONIC 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES L'OREAL (FR) 2014-12-04 US disclosed
WO-2013087931-A1 COUPLER WITH CATIONIC 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES L'OREAL (FR) 2013-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140352713-A1 COUPLER WITH CATIONIC 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES KRT18, PRMT7, ARGLU1 HRH3 29/4885BRD4 381/4885ATAD2 1655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.